Drug profile · INN
alendronate sodium trihydrate
ALENDRONIC ACID / COLECALCIFEROL MYLAN
alendronate sodium trihydrate (ALENDRONIC ACID / COLECALCIFEROL MYLAN) is a farnesyl diphosphate synthase inhibitor.
EMA: application withdrawn Musculo-skeletal system (M05) M05BB03
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — alendronate sodium trihydrate
- Class
- Musculo-skeletal system (M05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
alendronate sodium trihydrate (ALENDRONIC ACID / COLECALCIFEROL MYLAN) is a farnesyl diphosphate synthase inhibitor.
Key facts
INN alendronate sodium trihydrate
Brand ALENDRONIC ACID / COLECALCIFEROL MYLAN
Mechanism Farnesyl diphosphate synthase inhibitor
Target Farnesyl pyrophosphate synthase
Therapeutic class Musculo-skeletal system (M05)
ATC code M05BB03
Mechanism of action
Farnesyl diphosphate synthase inhibitor
Primary target: Farnesyl pyrophosphate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is alendronate sodium trihydrate?
alendronate sodium trihydrate (ALENDRONIC ACID / COLECALCIFEROL MYLAN) is a farnesyl diphosphate synthase inhibitor.
What is the brand name for alendronate sodium trihydrate?
ALENDRONIC ACID / COLECALCIFEROL MYLAN is a marketed brand name for alendronate sodium trihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.